Resideo Technologies stock price target raised to $48 by Oppenheimer

Resideo Technologies (NYSE: REZI) reported robust Q2 2025 results, exceeding EPS and revenue forecasts with strong organic growth and nine consecutive quarters of gross margin expansion in its Products & Solutions segment. Oppenheimer subsequently raised its price target to $48.00, maintaining an Outperform rating, citing the completion of an indemnification settlement, product innovation, and growth opportunities, alongside Clayton, Dubilier & Rice increasing its stake to approximately 19%. Morgan Stanley also upgraded REZI to Overweight, highlighting the company's earnings potential, as the stock has gained 79.57% year-to-date.

Analysis

Resideo Technologies (REZI) is demonstrating significant operational and market momentum, underpinned by robust Q2 2025 financial results that surpassed analyst expectations. The company reported earnings per share of $0.66 against a forecast of $0.54 and revenue of $1.94 billion versus an anticipated $1.83 billion, marking its strongest organic revenue growth in 15 quarters. This performance is further supported by nine consecutive quarters of gross margin expansion in its Products & Solutions segment. Consequently, analyst sentiment is strongly positive, with Oppenheimer reiterating an Outperform rating and increasing its price target to $48.00 from $35.00. Key drivers cited include the resolution of an indemnification settlement, product innovation, M&A opportunities in the ADI segment, and potential tailwinds from lower interest rates. Confidence is also bolstered by private equity firm Clayton, Dubilier & Rice increasing its stake to approximately 19%. However, some conflicting signals exist; while Morgan Stanley upgraded the stock to Overweight, its price target was set at $35.00, below the current trading price of $41.39. Additionally, despite the stock's 79.57% year-to-date gain, an embedded InvestingPro analysis suggests it may be trading above its fair value, introducing a note of caution regarding valuation.

Key Decisions for Investors

• Investors should weigh the strong fundamental momentum, evidenced by significant earnings beats and multiple analyst upgrades, against the stock's substantial 79.57% year-to-date appreciation and valuation concerns.
• Monitor the execution of key growth catalysts, including M&A activity within the ADI segment and expansion into the homebuilder channel, as these are critical to justifying further multiple expansion.
• Note the discrepancy between the bullish analyst ratings and the conflicting price target from Morgan Stanley ($35.00), which may warrant a cautious approach until a clearer consensus on valuation emerges.